Ueba T, Nosaka T, Takahashi J A, Shibata F, Florkiewicz R Z, Vogelstein B, Oda Y, Kikuchi H, Hatanaka M
Department of Neurosurgery, Faculty of Medicine, Kyoto University, Japan.
Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):9009-13. doi: 10.1073/pnas.91.19.9009.
Mutations of the p53 gene are found in various human cancers. The frequency of its mutation is reported to increase during tumor progression in most tumors. In human gliomas, mutations of the p53 gene are found in about one-third of the malignant forms and in few of the benign ones, indicating their possible involvement in tumor progression. On the other hand, we have recently shown that basic fibroblast growth factor (basic FGF) plays a crucial role in tumor progression as an autocrine growth factor in tissues of human gliomas. Therefore, we hypothesized that p53 might regulate the promoter activity of the basic FGF gene, which has several GC boxes and no typical TATA box. In this study, cotransfection assays using human glioblastoma and hepatocellular carcinoma cells and establishment of stable cell lines expressing mutant-type p53 were performed. The basic FGF gene promoter was demonstrated to be regulated by p53 at the transcriptional level and its basal core promoter was found to be responsive to p53. Expression of endogenous basic FGF was also demonstrated to be activated by mutant type p53. Wild-type p53 repressed gene expression of the basic FGF and its mutant activated it in vitro, implying one of the possible pathways in tumor progression.
p53基因的突变存在于多种人类癌症中。据报道,在大多数肿瘤的进展过程中,其突变频率会增加。在人类胶质瘤中,约三分之一的恶性肿瘤存在p53基因的突变,而良性肿瘤中则很少见,这表明它们可能参与了肿瘤进展。另一方面,我们最近发现碱性成纤维细胞生长因子(碱性FGF)作为人类胶质瘤组织中的自分泌生长因子,在肿瘤进展中起着关键作用。因此,我们推测p53可能调控碱性FGF基因的启动子活性,该基因有几个GC盒且无典型的TATA盒。在本研究中,我们使用人胶质母细胞瘤和肝癌细胞进行了共转染实验,并建立了表达突变型p53的稳定细胞系。结果表明,碱性FGF基因启动子在转录水平受p53调控,其基础核心启动子对p53有反应。内源性碱性FGF的表达也被证明可被突变型p53激活。野生型p53在体外抑制碱性FGF的基因表达,而其突变体则激活该表达,这暗示了肿瘤进展中一种可能的途径。